NANTES, France, April 23, 2018 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173) (Mnémo:OSE) has received the EuroNext Tech40 Label and is thus admitted to the “Tech40” index.